TMPRSS2:ERGGene Fusion Might Predict Resistance to PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer
Year: 2024
Type: article
Study design: Observational Study
Source: Anticancer Research
Institutions: Herlev Hospital, Rigshospitalet
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402986712
